BCA2/Rabring7 Promotes Tetherin-Dependent HIV-1 Restriction

• Kei Miyakawa,

  Affiliations AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan, Department of Molecular Virology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

  ⨯
• Akihide Ryo ,

  * E-mail: aryo@nih.go.jp (AR); nyama@nih.go.jp (NY)

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

  ⨯
• Tsutomu Murakami,

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

  ⨯
• Kenji Ohba,

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

  ⨯
• Shoji Yamaoka,

  Affiliation Department of Molecular Virology, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan

  ⨯
• Mitsunori Fukuda,

  Affiliation Department of Developmental Biology and Neurosciences, Graduate School of Life Sciences, Tohoku University, Sendai, Miyagi, Japan

  ⨯
• John Guatelli,

  Affiliation Department of Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Naoki Yamamoto

  * E-mail: aryo@nih.go.jp (AR); nyama@nih.go.jp (NY)

  Affiliation AIDS Research Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan

  ⨯